RPRX
NASDAQ
$58.42
Royalty Pharma plc - Class A (RPRX)
Royalty Pharma plc is a buyer of biopharmaceutical royalties and funder of innovations in the biopharmaceutical industry in the United States. The company is headquartered in New York, New York.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $59.89 (+2.52%)
Market Cap
$25B
Profit Margin
46.7%
P/E Ratio
28.69
Free Cash Flow Yield
10.62%
Price Chart
Valuation
Market Cap$25B
P/E28.69
Forward P/E48.08
PEG1.32
P/S13.14
P/B3.63
Profitability
Total Revenue (TTM)$2.44B
Gross Profit (TTM)$2.81B
EBITDA$1.59B
Profit Margin46.7%
Operating Margin89.3%
EPS$1.96
Financial Health
Debt-to-Equity90.1%
Free Cash Flow Yield10.62%
Dividend Yield1.53%
Growth & Risk
Revenue 5Y CAGR+2.82%
FCF 5Y CAGR+5.12%
Dividends 5Y CAGR+19.18%
Beta (5Y)0.25
Sharpe Ratio2.15